PITTSBURGH, PA – Dec. 6, 2011–– invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, today announced it has expanded its portfolio of global ePRO services by providing Asian language help desk support. Operated by invivodata’s service partner C3i Inc., in Dalian, China, invivodata’s help desk now provides comprehensive technical support in Chinese, Korean or Japanese. The Asian language help desk has been available since August 2011.
invivodata’s Asian language support service is an extension of it’s established strategic partnership with C3i, a leading IT services provider serving the life sciences industry. Through this partnership, invivodata delivers a scalable support solution with many benefits, including prompt and accurate resolution of inquiries, professionally-trained support staff with diverse language capabilities, real-time access to a detailed knowledge base, and sophisticated systems to log all calls.
“We are pleased to offer Asian language support as a key service to biopharmaceutical and medical device researchers who are using invivodata’s ePRO systems in their clinical trials throughout Asia,” said Dr. Wolfgang Summa, Vice President of Worldwide Operations at invivodata. “Through our experience in running over 350 global clinical trials to date, we have identified that a robust, native-language help desk is critical to ensuring smooth and successful ePRO implementation. This is especially true with Asian sites. By leveraging the existing support framework we have with C3i, we are able to seamlessly extend this valuable service, which enables us to meet the evolving needs of our new and existing customers as they expand into the Asian markets.”
“C3i is excited to expand its partnership with invivodata into Asia. Our operations center in Dalian leverages the tremendous experience we have providing clinical helpdesk support, training, and administrative services to leading sponsors, CROs and technology vendors globally. With dramatic growth projected in clinical trials, Asia represents a strategic region for the pharmaceutical industry and C3i/invivodata’s presence in China addresses the support needs of our customers doing business in the region,” said Joel Morse, CEO of C3i.
For additional information on invivodata’s global ePRO services, visit http://www.invivodata.com/solutions/proactive-epro-services/
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit www.invivodata.com.
Headquartered in Morristown, New Jersey, C3i Inc. has global operations centers in North America, Europe, India and China. Their 1200 employees provide systems implementation, technology training, multi-lingual help desk, hardware provisioning, and break/fix, asset management, and user/application administration services for pharmaceutical sales and clinical professionals worldwide. To learn more, visit us at www.c3i-inc.com and follow us on Twitter http://twitter.com/#!/C3i_Inc